Selected research
Industry Research
Biochemical Screening Test Industry Research Report 2026
Market perspective
The global Biochemical Screening Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biochemical Screening Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biochemical Screening Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biochemical Screening Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biochemical Screening Test include Yourgene Health, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc and BGI and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biochemical Screening Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biochemical Screening Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biochemical Screening Test Market by Company
Yourgene Health
Illumina Inc
Agilent Technologies Inc
Thermo Fisher Scientific Inc
Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
GE Healthcare
PerkinElmer Inc
BGI
Natera Inc
Biochemical Screening Test Segment by Type
Combined First Trimester Screening
Second Trimester Maternal Serum Screening
Biochemical Screening Test Segment by Application
Diagnostic Laboratories
Hospitals
Biochemical Screening Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biochemical Screening Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biochemical Screening Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biochemical Screening Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biochemical Screening Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Combined First Trimester Screening
- Second Trimester Maternal Serum Screening
Applications
- Diagnostic Laboratories
- Hospitals
Companies covered
- Yourgene Health
- Illumina Inc
- Agilent Technologies Inc
- Thermo Fisher Scientific Inc
- Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- GE Healthcare
- PerkinElmer Inc
- BGI
- Natera Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biochemical Screening Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Combined First Trimester Screening
- 2.2.3 Second Trimester Maternal Serum Screening
- 2.3 Biochemical Screening Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diagnostic Laboratories
- 2.3.3 Hospitals
- 2.4 Assumptions and Limitations
3 Biochemical Screening Test Breakdown Data by Type
- 3.1 Global Biochemical Screening Test Historic Market Size by Type (2021-2026)
- 3.2 Global Biochemical Screening Test Forecasted Market Size by Type (2027-2032)
4 Biochemical Screening Test Breakdown Data by Application
- 4.1 Global Biochemical Screening Test Historic Market Size by Application (2021-2026)
- 4.2 Global Biochemical Screening Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biochemical Screening Test Market Perspective (2021-2032)
- 5.2 Global Biochemical Screening Test Growth Trends by Region
- 5.2.1 Global Biochemical Screening Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biochemical Screening Test Historic Market Size by Region (2021-2026)
- 5.2.3 Biochemical Screening Test Forecasted Market Size by Region (2027-2032)
- 5.3 Biochemical Screening Test Market Dynamics
- 5.3.1 Biochemical Screening Test Industry Trends
- 5.3.2 Biochemical Screening Test Market Drivers
- 5.3.3 Biochemical Screening Test Market Challenges
- 5.3.4 Biochemical Screening Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biochemical Screening Test Players by Revenue
- 6.1.1 Global Top Biochemical Screening Test Players by Revenue (2021-2026)
- 6.1.2 Global Biochemical Screening Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Biochemical Screening Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biochemical Screening Test Head Office and Area Served
- 6.4 Global Biochemical Screening Test Players, Product Type & Application
- 6.5 Global Biochemical Screening Test Manufacturers Established Date
- 6.6 Global Biochemical Screening Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biochemical Screening Test Market Size (2021-2032)
- 7.2 North America Biochemical Screening Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biochemical Screening Test Market Size by Country (2021-2026)
- 7.4 North America Biochemical Screening Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biochemical Screening Test Market Size (2021-2032)
- 8.2 Europe Biochemical Screening Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biochemical Screening Test Market Size by Country (2021-2026)
- 8.4 Europe Biochemical Screening Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biochemical Screening Test Market Size (2021-2032)
- 9.2 Asia-Pacific Biochemical Screening Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biochemical Screening Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biochemical Screening Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biochemical Screening Test Market Size (2021-2032)
- 10.2 South America Biochemical Screening Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biochemical Screening Test Market Size by Country (2021-2026)
- 10.4 South America Biochemical Screening Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biochemical Screening Test Market Size (2021-2032)
- 11.2 Middle East & Africa Biochemical Screening Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biochemical Screening Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biochemical Screening Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Yourgene Health
- 12.1.1 Yourgene Health Company Information
- 12.1.2 Yourgene Health Business Overview
- 12.1.3 Yourgene Health Revenue in Biochemical Screening Test Business (2021-2026)
- 12.1.4 Yourgene Health Biochemical Screening Test Product Portfolio
- 12.1.5 Yourgene Health Recent Developments
- 12.2 Illumina Inc
- 12.2.1 Illumina Inc Company Information
- 12.2.2 Illumina Inc Business Overview
- 12.2.3 Illumina Inc Revenue in Biochemical Screening Test Business (2021-2026)
- 12.2.4 Illumina Inc Biochemical Screening Test Product Portfolio
- 12.2.5 Illumina Inc Recent Developments
- 12.3 Agilent Technologies Inc
- 12.3.1 Agilent Technologies Inc Company Information
- 12.3.2 Agilent Technologies Inc Business Overview
- 12.3.3 Agilent Technologies Inc Revenue in Biochemical Screening Test Business (2021-2026)
- 12.3.4 Agilent Technologies Inc Biochemical Screening Test Product Portfolio
- 12.3.5 Agilent Technologies Inc Recent Developments
- 12.4 Thermo Fisher Scientific Inc
- 12.4.1 Thermo Fisher Scientific Inc Company Information
- 12.4.2 Thermo Fisher Scientific Inc Business Overview
- 12.4.3 Thermo Fisher Scientific Inc Revenue in Biochemical Screening Test Business (2021-2026)
- 12.4.4 Thermo Fisher Scientific Inc Biochemical Screening Test Product Portfolio
- 12.4.5 Thermo Fisher Scientific Inc Recent Developments
- 12.5 Hoffmann-La Roche Ltd
- 12.5.1 Hoffmann-La Roche Ltd Company Information
- 12.5.2 Hoffmann-La Roche Ltd Business Overview
- 12.5.3 Hoffmann-La Roche Ltd Revenue in Biochemical Screening Test Business (2021-2026)
- 12.5.4 Hoffmann-La Roche Ltd Biochemical Screening Test Product Portfolio
- 12.5.5 Hoffmann-La Roche Ltd Recent Developments
- 12.6 Laboratory Corporation of America Holdings
- 12.6.1 Laboratory Corporation of America Holdings Company Information
- 12.6.2 Laboratory Corporation of America Holdings Business Overview
- 12.6.3 Laboratory Corporation of America Holdings Revenue in Biochemical Screening Test Business (2021-2026)
- 12.6.4 Laboratory Corporation of America Holdings Biochemical Screening Test Product Portfolio
- 12.6.5 Laboratory Corporation of America Holdings Recent Developments
- 12.7 GE Healthcare
- 12.7.1 GE Healthcare Company Information
- 12.7.2 GE Healthcare Business Overview
- 12.7.3 GE Healthcare Revenue in Biochemical Screening Test Business (2021-2026)
- 12.7.4 GE Healthcare Biochemical Screening Test Product Portfolio
- 12.7.5 GE Healthcare Recent Developments
- 12.8 PerkinElmer Inc
- 12.8.1 PerkinElmer Inc Company Information
- 12.8.2 PerkinElmer Inc Business Overview
- 12.8.3 PerkinElmer Inc Revenue in Biochemical Screening Test Business (2021-2026)
- 12.8.4 PerkinElmer Inc Biochemical Screening Test Product Portfolio
- 12.8.5 PerkinElmer Inc Recent Developments
- 12.9 BGI
- 12.9.1 BGI Company Information
- 12.9.2 BGI Business Overview
- 12.9.3 BGI Revenue in Biochemical Screening Test Business (2021-2026)
- 12.9.4 BGI Biochemical Screening Test Product Portfolio
- 12.9.5 BGI Recent Developments
- 12.10 Natera Inc
- 12.10.1 Natera Inc Company Information
- 12.10.2 Natera Inc Business Overview
- 12.10.3 Natera Inc Revenue in Biochemical Screening Test Business (2021-2026)
- 12.10.4 Natera Inc Biochemical Screening Test Product Portfolio
- 12.10.5 Natera Inc Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst